Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.

Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R.

Arch Intern Med. 2008 Dec 8;168(22):2415-21. doi: 10.1001/archinternmed.2008.506.

PMID:
19064823
2.

A comparative analysis of the results from 4 trials of beta-blocker therapy for heart failure: BEST, CIBIS-II, MERIT-HF, and COPERNICUS.

Domanski MJ, Krause-Steinrauf H, Massie BM, Deedwania P, Follmann D, Kovar D, Murray D, Oren R, Rosenberg Y, Young J, Zile M, Eichhorn E; BEST Investigators..

J Card Fail. 2003 Oct;9(5):354-63. Review.

PMID:
14583895
3.

Beta-blockade in heart failure: selective versus nonselective agents.

Metra M, Nodari S, Dei Cas L.

Am J Cardiovasc Drugs. 2001;1(1):3-14. Review.

PMID:
14728047
5.

Beta-blockers in heart failure: are pharmacological differences clinically important?

Metra M, Cas LD, di Lenarda A, Poole-Wilson P.

Heart Fail Rev. 2004 Apr;9(2):123-30. Review.

PMID:
15516860
6.

Are all beta-blockers the same for chronic heart failure?

Gottlieb SS.

Curr Cardiol Rep. 2001 Mar;3(2):124-9. Review.

PMID:
11177669
7.

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure.

Shibata MC, Flather MD, Wang D.

Eur J Heart Fail. 2001 Jun;3(3):351-7. Review.

8.

Beta-blockers: a new therapy in congestive heart failure.

Meghani SH, Becker D.

Am J Crit Care. 2001 Nov;10(6):417-27; quiz 428-9. Review.

PMID:
11688609
9.

[Elderly heart failure patients and the role of beta-blocker therapy].

Middeljans-Tijssen CW, Jansen RW.

Tijdschr Gerontol Geriatr. 2006 Apr;37(2):67-77. Review. Dutch.

PMID:
16704019
10.

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.

Chatterjee S, Biondi-Zoccai G, Abbate A, D'Ascenzo F, Castagno D, Van Tassell B, Mukherjee D, Lichstein E.

BMJ. 2013 Jan 16;346:f55. doi: 10.1136/bmj.f55. Review. Erratum in: BMJ. 2013;346:f596.

11.

Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.

Flannery G, Gehrig-Mills R, Billah B, Krum H.

Am J Cardiol. 2008 Mar 15;101(6):865-9. doi: 10.1016/j.amjcard.2007.11.023. Epub 2008 Feb 21. Review.

PMID:
18328855
12.

Pediatric heart failure therapy with beta-adrenoceptor antagonists.

Foerster SR, Canter CE.

Paediatr Drugs. 2008;10(2):125-34. Review.

PMID:
18345722
13.
14.

[Clinical trials of beta-blockers in heart failure: history, overview and future prospects].

Lechat P.

Therapie. 2004 Sep-Oct;59(5):517-26. Review. French.

PMID:
15648304
15.
16.

Cardiovascular drug class specificity: beta-blockers.

Reiter MJ.

Prog Cardiovasc Dis. 2004 Jul-Aug;47(1):11-33. Review.

PMID:
15517513
18.

Beta-blockers in chronic heart failure: considerations for selecting an agent.

Kukin ML.

Mayo Clin Proc. 2002 Nov;77(11):1199-206. Review.

PMID:
12440556
19.
20.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838

Supplemental Content

Support Center